Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Reagent sets and gene signatures for renal tubule injury

a technology of gene signatures and reagent sets, applied in the field of reagent sets and gene signatures for renal tubule injury, can solve the problems of renal failure among hospitalized patients, necrotic lesions of the tubules, expensive and long studies, etc., and achieve the effect of increasing the average performance of a depleted s

Inactive Publication Date: 2006-09-07
ENTELOS INC
View PDF53 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention provides methods, reagent sets, and gene sets for testing whether a compound will induce renal tubule injury in a test subject by measuring the expression levels of genes. The gene sets can be used to create linear or non-linear classifiers for renal tubule injury that are capable of accurately predicting whether a compound will cause injury or not. The methods involve administering a dose of the compound to a test subject and measuring the expression levels of genes at a later time point. The genes are chosen based on their impact on the development of renal tubule injury. The invention can be used in mammals, including humans, cats, dogs, mice, pigs, rabbits, and rats. The reagent sets and kits can include polynucleotides or polypeptides representing a plurality of genes. The invention provides a valuable tool for testing the early onset of renal tubule injury and can help to prevent the development of chronic kidney disease.

Problems solved by technology

Necrotic lesions of the tubules can arise as a consequence of septic, toxic or ischemic insult, and is a frequent cause of renal failure among hospitalized patients.
However, histopathological or clinical indications of kidney injury are not readily apparent in the early course of treatment, thus necessitating expensive and lengthy studies.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Reagent sets and gene signatures for renal tubule injury
  • Reagent sets and gene signatures for renal tubule injury
  • Reagent sets and gene signatures for renal tubule injury

Examples

Experimental program
Comparison scheme
Effect test

example 1

Construction of Chemogenomic Reference Database (DrugMatrix™)

[0110] This example illustrates the construction of a large multivariate chemogenomic dataset based on DNA microarray analysis of rat tissues from over 580 different in vivo compound treatments. This dataset was used to generate RTI signatures comprising genes and weights which subsequently were used to generate a necessary set of highly responsive genes that may be incorporated into high throughput diagnostic devices as described in Examples 2-7.

[0111] The detailed description of the construction of this chemogenomic dataset is described in Examples 1 and 2 of Published U.S. Pat. Appl. No. 2005 / 0060102 A1, published Mar. 17, 2005, which is hereby incorporated by reference for all purposes. Briefly, in vivo short-term repeat dose rat studies were conducted on over 580 test compounds, including marketed and withdrawn drugs, environmental and industrial toxicants, and standard biochemical reagents. Rats (three per group) w...

example 2

Preparation of a Chemogenomic Dataset for Late-Onset Renal Tubule Injury

[0115] This example describes methods used to prepare a chemogenomic dataset (i.e., a positive training set) for use deriving a signature for renal tubule injury (i.e., late-onset nephrotoxicity).

[0116] Overview

[0117] 28-day repeat dose studies were conducted on known nephrotoxicants. Doses were chosen that would not cause histological or clinical evidence of renal tubular injury after 5 days of dosing, but would cause histological evidence of tubular injury after 28 days of dosing. Animals were assigned to groups such that mean body weights were within 10% of the mean vehicle control group. Test compounds were administered either orally (10 ml of corn oil / kg body weight) or by intra-peritoneal injection (5 ml of saline / kg body weight). Animals were dosed once daily starting on day 0, and necropsied 24 hrs after the last dose following an overnight fast on day 5 (n=5) and day 28 (n=10). An equivalent number o...

example 3

Derivation of a Predictive Renal Tubule Injury Signature

[0138] Overview

[0139] The support vector machine algorithm was trained to classify experimentally confirmed nephrotoxicants from non-nephrotoxicants using the data acquired in Examples 1 and 2 above. A linear classifier (i.e., gene signature) was derived using kidney expression profiles from rats treated with 15 nephrotoxicants that induce renal tubular injury after 4 weeks of daily dosing, and 49 non-nephrotoxicants known not to induce renal tubular injury under subchronic dosing conditions.

[0140] Gene Signature Derivation

[0141] To derive the gene signature, a three-step process of data reduction, signature generation and cross-validation of the predictive signature was used. A total of 7478 gene probes from the total of 10,000 on the CodeLink™ RU1 microarray were pre-selected based on having less than 5% missing values (e.g., invalid measurement or below signal threshold) in either the positive or negative class of the tr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
timeaaaaaaaaaa
timeaaaaaaaaaa
timeaaaaaaaaaa
Login to View More

Abstract

The invention discloses reagent sets and gene signatures for predicting onset of renal tubule injury in a subject. The invention also provides a necessary set of 186 genes useful for generating signatures of varying size and performance capable of predicting onset of renal tubule injury. The invention also provides methods, apparatuses and reagents useful for predicting future renal tubule injury based on expression levels of genes in the signatures. In one particular embodiment the invention provides a method for predict whether a compound will induce renal tubule injury using gene expression data from sub-acute treatments.

Description

CROSS REFERENCE TO RELATED APPLICATIONS [0001] This application is a continuation-in-part of U.S. patent application Ser. No. 11 / 184,272, filed on Jul. 18, 2005, which claims priority from U.S. Provisional Application No. 60 / 589,409, filed Jul. 19, 2004, each of which is hereby incorporated by reference herein in its entirety.FIELD OF THE INVENTION [0002] This invention relates to reagent sets and gene signatures useful for predicting the onset of renal tubule injury (RTI) in a subject. The invention also provides methods, apparatuses and kits useful for predicting occurrence of renal tubule injury based on expression levels of genes in the signatures. In one embodiment the invention provides a method for predicting whether a compound will induce renal tubule injury using gene expression data from sub-acute treatments. BACKGROUND OF THE INVENTION [0003] Renal tubule injury (also referred to herein as, “tubular nephrosis”) is a common drug-induced toxicity that includes degenerative ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C12Q1/68G01N33/53C12M1/34
CPCG01N33/6893G01N2500/00G01N2800/347
Inventor NATSOULIS, GEORGESFIELDEN, MARKJARNAGIN, KURTKOLAJA, KYLE
Owner ENTELOS INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com